Viewing Study NCT04358393


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2025-12-27 @ 2:39 AM
Study NCT ID: NCT04358393
Status: RECRUITING
Last Update Posted: 2024-02-01
First Post: 2020-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module